ArticleOpen forum infectious diseases2022

Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies.

Camille Vellas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.